Search Results - "Montigny, C. de"

Refine Results
  1. 1

    Differences between Males and Females in Rates of Serotonin Synthesis in Human Brain by Nishizawa, S., Benkelfat, C., Young, S. N., Leyton, M., Mzengeza, S., De Montigny, C., Blier, P., Diksic, M.

    “…Rates of serotonin synthesis were measured in the human brain using positron emission tomography. The sensitivity of the method is indicated by the fact that…”
    Get full text
    Journal Article
  2. 2

    Treatment resistant depression: methodological overview and operational criteria by Souery, D, Amsterdam, J, de Montigny, C, Lecrubier, Y, Montgomery, S, Lipp, O, Racagni, G, Zohar, J, Mendlewicz, J

    Published in European neuropsychopharmacology (1999)
    “…A wide variety of definitions are used for Treatment Resistant Depression (TRD), considering various criteria and different concepts. Some of the key issues…”
    Get full text
    Journal Article
  3. 3

    Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors by Debonnel, G, Bergeron, R, de Montigny, C

    Published in Journal of endocrinology (01-09-1996)
    “…We have previously shown in vivo that low doses of selective sigma (sigma) receptor ligands potentiate selectively and dose-dependently the excitatory response…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain by Kasamo, K, Blier, P, De Montigny, C

    “…In in vitro uptake experiments, duloxetine inhibited [3H]5-hydroxytryptamine (5-HT) and [3H]norepinephrine (NE) uptake in hippocampus slices of control rats…”
    Get more information
    Journal Article
  6. 6

    Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors by Bergeron, R, de Montigny, C, Debonnel, G

    Published in The Journal of neuroscience (01-02-1996)
    “…We have shown previously that low doses of selective sigma (sigma)-receptor ligands potentiate the excitatory response of pyramidal neurons to NMDA in the CA3…”
    Get full text
    Journal Article
  7. 7

    In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands by Monnet, F P, Debonnel, G, de Montigny, C

    “…We have reported previously that the high affinity sigma ligand DTG potentiates N-methyl-D-aspartate (NMDA)-induced excitation of pyramidal neurons in the CA3…”
    Get more information
    Journal Article
  8. 8

    Differential effects of sigma ligands on the N-methyl- d-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: Effect of Mossy fiber lesioning by Debonnel, G., Bergeron, R., Monnet, F.P., de Montigny, C.

    Published in Neuroscience (01-04-1996)
    “…In the CA3 region of rat dorsal hippocampus, several σ ligands, such as 1,3-di(2-tolyl)guanidine (DTG), (+)-pentazocine and (+)- N-cyclopropylmethyl-…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate by Bergeron, R, de Montigny, C, Debonnel, G

    “…Previous studies from our laboratory have demonstrated that low doses of selective sigma (sigma) ligands potentiate the neuronal response to…”
    Get full text
    Journal Article
  11. 11

    Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders by Dé Montigny, C, Grunberg, F, Mayer, A, Deschenes, J P

    Published in British journal of psychiatry (01-03-1981)
    “…Eight patients suffering from a major unipolar depression and having field to respond to treatment for three weeks or more with tricyclic antidepressants were…”
    Get more information
    Journal Article
  12. 12

    Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial by Fabre, I., Galinowski, A., Oppenheim, C., Gallarda, T., Meder, J. F., de Montigny, C., Olié, J. P., Poirier, M. F.

    “…Background Beneficial effects of repetitive transcranial magnetic stimulation (rTMS) were demonstrated by many controlled studies in major depression…”
    Get full text
    Journal Article
  13. 13

    Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment by Welner, S A, De Montigny, C, Desroches, J, Desjardins, P, Suranyi-Cadotte, B E

    Published in Synapse (New York, N.Y.) (1989)
    “…There is growing evidence that the serotonergic (5-HT) system is involved in the pathogenesis and treatment of major depression. The 5-HT receptor subtype…”
    Get more information
    Journal Article
  14. 14

    Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor by Monnet, F P, Debonnel, G, Fournier, A, de Montigny, C

    “…In an in vivo electrophysiological paradigm, we have shown in the companion paper that neuropeptide Y (NPY) potentiates N-methyl-D-aspartate (NMDA)-induced…”
    Get more information
    Journal Article
  15. 15

    Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alpha-2 adrenoceptors modulating serotonin neurotransmission by Mongeau, R, de Montigny, C, Blier, P

    “…Previous results from our laboratory indicate that small doses of the alpha-2 adrenergic agonist clonidine increase serotonin (5-HT) neurotransmission by…”
    Get more information
    Journal Article
  16. 16

    Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors by Szabo, Steven T., de Montigny, Claude, Blier, Pierre

    “…Sustained administration of the selective serotonin (5-HT) reuptake inhibitors (SSRIs) citalopram for 2, 14, and 21 d, and paroxetine for 2 and 21 d (20 and 10…”
    Get full text
    Journal Article
  17. 17

    The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments by Mongeau, R, Blier, P, de Montigny, C

    Published in Brain Research Reviews (01-04-1997)
    “…Previous reviews have well illustrated how antidepressant treatments can differentially alter several neurotransmitter systems in various brain areas. This…”
    Get full text
    Book Review Journal Article
  18. 18

    Characterization of 5-hydroxytryptamine1A properties of flesinoxan : in vivo electrophysiology and hypothermia study by HADRAVA, V, BLIER, P, DENNIS, T, ORTEMANN, C, DE MONTIGNY, C

    Published in Neuropharmacology (01-10-1995)
    “…Flesinoxan is a high affinity and selective 5-hydroxytryptamine1A (5-HT1A) ligand which, unlike the 5-HT1A agonists of the azapirone class, does not generate…”
    Get full text
    Journal Article
  19. 19

    A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence by Blier, P, de Montigny, C, Chaput, Y

    Published in The journal of clinical psychiatry (01-04-1990)
    “…The electrophysiologic assessment of the action of different types of antidepressant treatments on the serotonin (5-hydroxytryptamine [5-HT]) system revealed…”
    Get full text
    Journal Article
  20. 20

    Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain by Haddjeri, N, Blier, P, de Montigny, C

    “…Mirtazapine ([(+/-)-MIR], Remeron, ORG 3770) is an alpha-2 adrenoceptor antagonist endowed with antidepressant activity in humans. The aim of the present study…”
    Get more information
    Journal Article